Mimedx (MDXG) Shareholder's Equity Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 149.53% |
| Dec 31, 2025 | 153.35% |
| Sep 30, 2025 | 142.39% |
| Jun 30, 2025 | 161.71% |
| Mar 31, 2025 | 208.21% |
| Dec 31, 2024 | 1,230.44% |
| Sep 30, 2024 | 221.29% |
| Jun 30, 2024 | 194.51% |
| Mar 31, 2024 | 177.39% |
| Dec 31, 2023 | 884.23% |
| Sep 30, 2023 | -53.07% |
| Jun 30, 2023 | -36.69% |
| Mar 31, 2023 | -37.36% |
| Dec 31, 2022 | -36.13% |
| Sep 30, 2022 | -35.60% |
| Jun 30, 2022 | -36.64% |
| Mar 31, 2022 | -29.94% |
| Dec 31, 2021 | -88.18% |
| Sep 30, 2021 | -27.42% |
| Jun 30, 2021 | -27.81% |
| Mar 31, 2021 | -28.20% |
| Dec 31, 2020 | -26.03% |
| Sep 30, 2020 | -55.13% |
| Jun 30, 2020 | -46.26% |
| Mar 31, 2020 | -38.28% |
| Dec 31, 2019 | -10.55% |
| Sep 30, 2019 | -31.53% |
| Jun 30, 2019 | -41.23% |
| Mar 31, 2019 | -30.50% |
| Dec 31, 2018 | 12.66% |
| Sep 30, 2018 | -5.55% |
| Jun 30, 2018 | -4.52% |
| Mar 31, 2018 | -4.50% |
| Dec 31, 2017 | -6.17% |
| Sep 30, 2017 | 20.58% |
| Jun 30, 2017 | 25.51% |
| Mar 31, 2017 | 19.17% |
| Dec 31, 2016 | -13.23% |
| Sep 30, 2016 | 51.38% |
| Jun 30, 2016 | 54.63% |
| Mar 31, 2016 | 53.49% |
| Dec 31, 2015 | 20.18% |
| Sep 30, 2015 | 73.69% |
| Jun 30, 2015 | 81.21% |
| Mar 31, 2015 | 90.51% |
| Dec 31, 2014 | 95.81% |
| Sep 30, 2014 | 89.97% |
| Jun 30, 2014 | 79.29% |
| Dec 31, 2013 | 129.32% |